A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients with Muscle-Invasive Bladder Cancer with Bladder Preservation for those Patients whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations (Alliance A031701)
- Citation:
- J Clin Oncol vol 40 (16_suppl) TPS4615-TPS4615
- Meeting Instance:
- ASCO 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Gopa Iyer Karla V. Ballman Pamela Atherton Katie Murray Young Kwok Preston Steen Shiva Baghaie Jonathan E. Rosenberg Michael J. Morris
- Networks:
- LAPS-NY016, MD015, MO036, SANFORD
- Study
- Alliance-A031701
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: